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ACH year, approximately 200 of 1 million individuals
experience TBI. The population with TBI consists of
approximately 25% female patients.25 The effect of
sex on TBI outcome is controversial. In a retrospective clin-
ical study, Coimbra, et al.,4 concluded that sex does not play
a role in death following trauma or in the incidence of acute
complications after any degree of closed-head injury. Note,
however, that authors of other clinical studies assert that
female persons may have a greater risk for worse long-term
outcomes compared with male individuals.8,24 In preclinical
studies, Kupina and colleagues11 found that peak protein
degradation and neurodegeneration occurred within 3 days
after TBI in male mice, whereas these processes did not
occur until 14 days after TBI in female mice. Furthermore,
20% of male mice with TBI died within a short period im-
mediately following injury, whereas all female mice with
TBI survived despite having the same degree of damage.
Female rats are reported to have smaller areas of damaged
brain compared with those in both ovariectomized rats and
male rats following parasagittal fluid-percussion brain inju-
ry, thus indicating a hormonally dependent neuroprotective
effect.1 Although the effect of sex on the pathophysiologi-
cal mechanisms and degree of recovery following TBI are
areas of intense investigation, what has not been studied is
whether there is a sex-dependent response to therapeutic in-
terventions for TBI, particularly neurorestorative therapy.
In an attempt to reduce neurological deficits and to res-
cue damaged neurons caused by TBI, we tested the effect of
atorvastatin, a b-hydroxy-b-methylglutaryl coenzyme A re-
ductase inhibitor, in a controlled cortical impact model in
the male rat.12 Male rats treated with atorvastatin starting 1
day after TBI exhibit significant functional improvement in
somatosensory response and a learning paradigm as well as
concomitant induction of brain plasticity and a reduction in
microvascular coagulation.14,15 To our knowledge, however,
there have been no studies focused on the response of fe-
male rats subjected to TBI and treated with atorvastatin.
Note that differential sex effects of atorvastatin have been
reported. For example, atorvastatin increases the anticoagu-
lant effect of warfarin in postmenopausal women but not in
men of the same age.19 We therefore designed the present
study to test the atorvastatin treatment effect on sensorimo-
tor function and spatial learning as well as on induction of
neuroplasticity in the injured brain of female rats subjected
to TBI.
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Object. Atorvastatin administered after traumatic brain injury (TBI) induced by controlled cortical impact promotes
functional improvement in male rats. Note, however, that parallel studies have not been performed in female rats.
Therefore, the authors tested the effect of atorvastatin on TBI in female rats.
Methods. Atorvastatin (1 mg/kg/day) was orally administered for 7 consecutive days in female Wistar rats starting
1 day after TBI; control animals received saline. Modified neurological severity scores, the corner turn test, and the
Morris water maze test were used to evaluate functional response to treatment. Rats were killed on Day 15 post-TBI,
and brain tissue samples were processed for immunohistochemical staining. Atorvastatin administration after brain in-
jury significantly promoted the restoration of spatial memory but did not reduce sensorimotor functional deficits. Treat-
ment of TBI with atorvastatin increased neuronal survival in the CA3 region and the lesion boundary zone and pre-
vented the loss of neuronal processes of damaged neurons in the hippocampal CA3 region but not in the lesion
boundary zone on Day 15 after TBI. The protective effect of atorvastatin on the injured neurons perhaps is mediated
by increasing the density of vessels in the lesion boundary zone and the hippocampus after TBI.
Conclusions. These data indicate that atorvastatin is beneficial in the treatment of TBI in female rats, although the
effect may differ between sexes.
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Abbreviations used in this paper: DG = dentate gyrus; MNSS =
modified neurological severity score; PBS = phosphate-buffered sa-
line; TBI = traumatic brain injury; VWF = von Willebrand factor.
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All experimental procedures were approved by the Care of Exper-
imental Animals Committee of Henry Ford Hospital.
Animal Model
A controlled cortical impact model of TBI in rats was used in the
present study.7,18 Female Wistar rats weighing 300 to 350 g each
were anesthetized intraperitoneally with chloral hydrate (350 mg/kg
body weight). Rectal temperature was maintained at 37˚C by using a
feedback-regulated water heating pad. A controlled cortical impact
device was used to induce injury. Rats were placed in a stereotactic
frame. Two 10-mm-diameter craniotomies were performed adjacent
to the central suture, midway between the lambda and bregma. The
second craniotomy allowed for lateral movement of cortical tissue.
The dura mater was kept intact over the cortex. Injury was induced
by impacting the left cortex (ipsilateral cortex) with a pneumatic pis-
ton containing a 6-mm-diameter tip at a rate of 4 m/second and 2.5
mm of compression. Velocity was measured with a linear velocity
displacement transducer. Brain injury in this model is characterized
by cystic cavity formation in cortex, which causes asymmetric neu-
rological deficits17 and selective cell damage in hippocampal forma-
tion, causing spatial memory dysfunction.12 Therefore, sensorimotor
and spatial memory tests were used to evaluate functional response
to injury and treatment after TBI.
Sensorimotor Functional Tests
The measurement of sensorimotor function was performed using
an MNSS2,13,23 and a corner turn test.9,27 These measures were con-
ducted in all rats before injury and on Days 1, 5, 8, and 15 after TBI.
The MNSS is a composite of motor (muscle status and abnormal
movement), sensory (visual, tactile, and proprioceptive), beam bal-
ance, and reflex tests. Motor tests of the MNSS include seven items
with a maximum score of 3 points, which mainly reflect the function
of the motor representation area in the contralateral cortex. Damage
to this area causes contralateral limb paralysis, leading to high scores
on the MNSS motor tests. Sensory tests include two items with a
maximum score of 2, reflecting a combination of visual, tactile, and
deep sensations. A unilateral lesion in the sensory and motor repre-
sentations of the forelimb in the somatosensory cortex can produce
contralateral asymmetry.5,6,26 The placing test, included as a sensory
test of the MNSS, also reflects an aspect of motor function, because
the corticospinal pathway mediates the execution of the placing re-
action and lesions in this region produce an enduring forelimb-plac-
ing deficit.20 Beam balance tests, part of the asymmetry test, contain
seven items with a maximum score of 6, mainly reflecting hind-
limb placing performance, which is controlled by the contralateral
cortical representation of motor function. Damage to this area caus-
es dragging of the contralateral hindlimb (the hindlimb is not placed
on the beam), or the hindlimb is placed on the vertical surface of the
beam to help support the animal’s weight and to aid in maintaining
balance, which reflects a high score on the beam balance tests. The
last part of the MNSS includes the pinna, corneal and startle reflex-
es, and abnormal movements. In this model, injury in the left hemi-
sphere cortex of rats causes sensory and motor functional deficits
with elevated scores on motor, sensory, and beam balance tests in the
early phase after injury (Day 1 postinjury).16 Absent reflexes and ab-
normal movements are present in rats with severe injury.
The corner turn test was developed for measuring long-term func-
tion recovery in the rat.9 The test is sensitive to unilateral cortical
injury because it reflects multiple asymmetries, including postural,
vibrissae sensory, and fore- and hindlimb use asymmetries, which
all combine to bias turning. An uninjured rat randomly turns left or
right, whereas an injured rat preferentially turns toward the unim-
paired ipsilateral (left) side. We recorded the number of right turns
from 10 trials for each test and used the results for statistical analy-
sis.9 Recovery in asymmetry deficiency as reflected by the beam bal-
ance test and the corner turn test has been reported in unilateral brain
injury such as brain trauma,21 brain hemorrhage,9 and stroke.27 These
tests are suitable for neurological functional evaluation after unilat-
eral brain injury. 
Spatial Memory Test Procedures
Our spatial memory testing procedure is a modification of the
Morris water maze test, as described previously.5,6,12,26 Data collec-
tion was automated using the HVS Image 2020 Plus Tracking Sys-
tem (US HVS Image, San Diego, CA). For the training trials, each
animal performed one trial per day for a 5-day session, with a 3-day
break between the final training session and brain injury. The rats
were then tested on Days 4, 8, and 15 after TBI or surgery. At the
start of a trial, the rat was randomly placed at one of four fixed start-
ing points, randomly facing either toward the wall or inwardly (des-
ignated north, south, east, and west), and was allowed to swim for
90 seconds or until it found the platform. The platform was locat-
ed in a randomly changing position within the northeast quadrant
throughout the test period (for example, sometimes equidistant from
the center and edge of the pool, against the wall, near the center of
the pool, or at the edges of the northeast quadrant). If the animal was
unable to find the platform within 90 seconds, the experiment was
terminated and a maximal score of 90 seconds was assigned. The
percentage of time traveled within the northeast (correct) quadrant
was calculated relative to the total amount of time spent swimming
before reaching the platform.
Experimental Groups
Ten female Wistar rats were randomly divided into two groups
(five animals/group). Five rats were subjected to TBI followed by
the oral administration of atorvastatin (1 mg/kg/day) 1 day after TBI
for 7 consecutive days. An additional five rats subjected to TBI were
treated with oral saline at the same dose and for the same period. The
atorvastatin dose was selected based on prior work on stroke and
TBI.12 All rats were killed 15 days after TBI.
Tissue Preparation
Fifteen days after TBI, the rats were anesthetized intraperitoneal-
ly with ketamine and xylazine and were perfused transcardially with
saline solution containing heparin, followed by 4% paraformalde-
hyde in 0.1 M PBS (pH 7.4). Their brains were removed, postfixed
in 10% formalin for 1 to 2 days at room temperature, and then pro-
cessed for paraffin sectioning. A series of 6-mm-thick tissue sections
were cut using a microtome through each of seven standard blocks.
A section from every block was stained with H & E for the calcula-
tion of lesion volume.
Immunofluorescence Studies
After dehydration, tissue sections were boiled in 1% citric acid
buffer (pH 6) in a microwave oven for 10 minutes, cooled to room
temperature, and incubated in 1% saponin for 3 hours. Subsequently,
the sections were incubated in 1% bovine serum albumin to block
the nonspecific signals. Using the same buffer solution, the sections
were incubated overnight at 4˚C in primary antibody (monoclonal
mouse anti–MAP2, dilution 1:400; Chemicon, Temecula, CA), fol-
lowed by 2 hours at room temperature in corresponding fluoro-
chrome-conjugated secondary antibody (anti–mouse fluorescein iso-
thiocyanate; Jackson ImmunoResearch, West Grove, PA). Each of
the aforementioned steps was followed by four 5-minute rinses in
PBS. The sections were counterstained with propidium iodide for the
identification of nuclei. Tissue sections were mounted on slides with
ProLong antifade medium (Molecular Probes, Eugene, OR). Sec-
tions were observed with the aid of a fluorescent microscope.
Immunoperoxidase Staining
To identify the vascular structure, brain tissue sections, after being
deparaffinized, were incubated in 2% bovine serum albumin/PBS at
room temperature for 30 minutes and subsequently were treated with
mouse anti–VWF antibody (Dako Cytomation, Carpinteria, CA) di-
luted to 1:200 in PBS at 4˚C overnight. Following sequential in-
cubation with biotin-conjugated anti–mouse immunoglobulin G (di-
lution 1:100; Dakopatts, Carpinteria, CA), the sections were treated
with an avidin-biotin-peroxidase system (ABC kit; Vector Laborato-
ries, Inc., Burlingame, CA). Diaminobenzidine was then used as a
sensitive chromogen for light microscopy.
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To evaluate whether orally administered atorvastatin reduces neu-
ronal damage after TBI, cell counts were performed by observers
blinded to the individual treatment status of the animals. The MAP2-
positive cells were defined as surviving neurons and counted in the
CA3 region of the hippocampal formation and the boundary zone of
the injured cortex. Counting of neurons with axons and dendrites
was also performed in these regions in the tissues from the two
groups, and the percentage of neurons with an axon and dendrites
was used as a parameter to evaluate the effect of the atorvastatin
treatment. Five tissue sections cut at 50-mm intervals through the
dorsal DG were analyzed with the aid of a fluorescent microscope 3
200 (at the interaural 5.2-mm levels). Using an image analyzer
(MCID; St. Catharines, ON, Canada), the numbers of MAP2-posi-
tive cells were counted as surviving neurons per square millimeter in
the CA3 region of the ipsilateral hippocampus.
Boundary Zone of the Injured Cortex
The MAP2-positive cells in the boundary zone of the injury were
counted as the surviving neurons per square millimeter on the same
sections as those used for the hippocampus. The boundary zone
was defined as the area surrounding the lesion cavity, which mor-
phologically differs from surrounding intact brain tissue. Surviving
neuronal cells were calculated as a density (cell number per square
millimeter) in the lesion boundary zone and as the number of MAP2-
positive cells per millimeter in the hippocampal CA3 region.
Volumetric Analysis
To estimate the lesion volume of the cortex, tissue sections were
stained with H & E and were analyzed using a 103 objective and a
computer imaging analysis system.28 Lesion volume was calculated
by measuring the area of the lesion, including the lesion cavity and
boundary zone, from each section and multiplying the lesion area by
the section thickness and the sampling intervals. 
Measurement of Vascular Density
Five sections with 50-mm intervals through the dorsal DG were
stained for VWF, and the images were digitized using a light mi-
croscope 3 400 (at the interaural 5.2-mm levels). The VWF-posi-
tive vessels were counted in the boundary zone of the lesion and the
CA3 region of the hippocampus by using the image analyzer sys-
tem (MCID). The vascular density in both regions was determined
by dividing the number of immunoreactive vessels by the corre-
sponding area.28
Statistical Analysis
All data are presented as the means 6 standard deviation. Data
were analyzed using an analysis of variance for repeated measures of
functional test data.17 A paired t-test was used to consider the differ-
ence in cell counts as well as in vascular density in the ipsilateral
hemisphere between the atorvastatin-treated group and the control
group. All measures were analyzed by observers blinded to individ-
ual treatments. 
Results
Neurological and Sensorimotor Functional Responses
Injury in the left hemisphere cortex in rats caused neu-
rological functional deficits as measured using the MNSS.
These rats presented with high scores on motor, sensory,
and beam balance tests on Day 1 postinjury (Table 1). Ab-
sent reflexes and abnormal movements were evident in rats
with severe injury. By Day 15 postinjury, residual deficit
scores were associated mainly with the beam balance tests
and the sensory (placing) test of the MNSS. The MNSS
scores for the atorvastatin-treated group (3.4 6 1.1) were
not significantly decreased on Day 15 after TBI when com-
pared with those in the saline-treated group (3.8 6 1.3; p .
0.05). There was also no significant difference on the cor-
ner turn test between the atorvastatin- and saline-treated
animals at any time point. These data demonstrate that ator-
vastatin does not significantly reduce asymmetry deficien-
cies caused by TBI in female Wistar rats.
Spatial Memory Test
On the 1st day of training, the mean percent of time spent
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TABLE 1
Neurological functional response after atorvastatin
treatment in rats subjected to TBI*
Postinjury Day
Test Preinjury 1 8 15
MNSS
control 0 14 6 1.3 6.0 6 1.4 3.4 6 1.4
atorvastatin- 0 13 6 0.9 6.2 6 0.8 3.8 6 1.3
treated
corner turn test
control 4.8 6 0.5 2.0 6 0.5 3.0 6 1.0 3.8 6 0.8
atorvastatin- 5.0 6 0.7 2.2 6 0.7 2.4 6 1.5 3.8 6 1.6
treated
* Values are presented as the means 6 standard deviations.
FIG. 1. Graph showing the effect of atorvastatin on the spatial
memory in female rats after TBI, measured by the Morris water
maze test. Preinjury training of female rats significantly augmented
the time spent in the correct quadrant, which was measured 4 and 8
days following initial training. At 4 days post-TBI, the time spent in
the correct quadrant significantly decreased, and atorvastatin treat-
ment significantly increased the restoration of spatial memory on
Day 15 after TBI when compared with that in the saline-treated
group (*p , 0.05). These data demonstrate that the Morris water
maze test is a sensitive test by which the enhancement, deficits, and
restoration of the spatial memory function after TBI can be mea-
sured. Atorvastatin significantly promotes improvement of spatial
memory after TBI in female Wistar rats. SE = standard error.
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proximately 27% and persistently increased during the sub-
sequent training days, reaching approximately 40% after
five daily training sessions (Fig. 1). The rats subjected to
TBI spent a significantly diminished percentage of time
in the correct quadrant 4 days after TBI. These data dem-
onstrate that brain damage in this model causes significant
dysfunction of spatial memory in female rats, results that
can indicate a target for the treatment of the injury.
The percentage of time spent in the correct quadrant was
significantly greater in the atorvastatin-treated group on
Day 15 post-TBI (47.1 6 8.8%) compared with that in the
saline-treated group (38 6 2.29%; p , 0.05). These data
demonstrate that atorvastatin administration enhances the
restoration of spatial memory function damaged in TBI in
female Wistar rats.
Lesion Volume
Using the image analyzer system, the lesion volume, in-
cluding both the cavity and the lesion boundary zone in the
cortex, was calculated in both groups. There was no sig-
nificant difference in lesion volume between the atorva-
statin- and saline-treated groups (9.38 6 3.05% compared
with 10.66 6 5.95%, respectively; p . 0.05). These data
demonstrate that atorvastatin does not significantly reduce
lesion volume in female rats after TBI.
Neuron Survival in the Boundary Zone and the CA3
Region of the Hippocampus
Surviving neurons in the lesion boundary zone and the
hippocampal CA3 region were counted on the MAP2-
stained slides. Compared with those in the contralateral
hemisphere, surviving neurons in the lesion boundary zone
after TBI lose pyramidal cell features, such as a long axon,
and many processes. The density of the neuronal cells in
the lesion boundary zone of the atorvastatin-treated group
(25.7 6 5.2/mm2) was significantly greater than that in the
saline-treated group (16.5 6 3.4/mm2; p , 0.05; Fig. 2a).
In the hippocampal CA3 region, atorvastatin treatment sig-
nificantly enhanced survival of pyramidal cells (94.6 6
17.2/mm) when compared with saline treatment (58.9 6
18.8/mm; p , 0.05; Fig. 2b), indicating that atorvastatin
can play a role in protecting damaged neurons in the lesion
boundary zone and hippocampal areas from death induced
by TBI.
Morphologically, neurons in the pyramidal cell layer of
the CA3 region in the contralateral hippocampus have a
polygonal large body with a long axon projecting to the
stratum lucidum (Fig. 3a1 and a2). After TBI, pyramidal
cells in the CA3 region lose these normal features and there
is significant loss of axons and dendrites (Fig. 3b1 and b2).
The percentage of surviving neurons with an axon and den-
drites in the CA3 region (78 6 9%) following atorvastatin
C. Qu, et al.
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FIG. 2. Bar graphs showing atorvastatin-augmented numbers of surviving neurons in the lesion boundary zone (a) and
the hippocampal CA3 region (b) and percentages of neurons with processes in the hippocampal CA3 region (c) but not in
the lesion boundary zone (d).
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lowing saline treatment (44 67%; p ,0.05; Fig. 2c). In the
atorvastatin-treated group, many surviving neurons exhibit
features of normal neurons, such as the long axon and nu-
merous dendrites (Fig. 3c1 and c2). No significant differ-
ence occurred in the percentage of surviving neurons with
processes in the lesion boundary zone between the atorva-
statin- and saline-treated groups (39 6 13% compared with
32 6 9%, respectively; p . 0.05; Fig. 2d). These data dem-
onstrate that atorvastatin reduces the loss of the neurons and
their processes in the CA3 region but not in the lesion boun-
dary zone in female Wistar rats subjected to TBI.
Vascular Changes After TBI
The numbers of vessels were measured in the lesion
boundary zone of the injured cortex and the CA3 region
of the hippocampus by counting VWF-positive vessels per
square millimeter, regardless of the vessel size. Vessel den-
sity was significantly greater in the atorvastatin-treated
group than in the saline-treated group in the lesion bound-
ary zone (34 6 5/mm2 compared with 18 6 1.6/mm2, p ,
0.05) and in the hippocampal CA3 region (19 6 3/mm2
compared with 7 6 2/mm2, p , 0.05; Fig. 4). These data
demonstrate that atorvastatin enhances vascular density in
the injured brain in female rats after TBI. 
Discussion
Our main findings in this study regarding atorvastatin
treatment of TBI in the female rat are as follows. Atorvasta-
tin treatment significantly improves spatial memory but not
sensorimotor functional outcome, augments the number of
surviving neurons in the lesion boundary zone and hippo-
campal CA3 region, enhances the percentage of the neurons
with processes in the hippocampal CA3 region, and increas-
es vascular density in these two regions.
In the controlled cortical impact model of TBI, the im-
pact selectively damages the pyramidal hippocampal CA3
region and causes contusion of the cortex in the ipsilater-
al hemisphere. These pathological changes contribute to
deficits in neurological function, including sensorimotor
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FIG. 3. Photomicrographs showing MAP2 staining (green) and counterstaining with propidium iodide (red). The CA3
region close to the DG (a1) and the CA3 region adjacent to the CA2 region (a2) reveal neurons marked by MAP2 in the
contralateral hippocampal CA3 region. b1 and b2: Decreased numbers of neurons are present in the CA3 region with sa-
line treatment after TBI. c1 and c2: Atorvastatin increases neuronal survival in the CA3 region after TBI. Pyramidal cells
with long axons and many dendrites are present in the contralateral CA3 regions (a2) and a reduction of pyramidal cells
and their processes appears after TBI (b2). Significantly, more MAP2-positive cells are found in the CA3 region after ator-
vastatin treatment (c1 and c2) when compared with the saline-treated (b1 and b2) group, but less than in the contralateral
CA3 region (a1 and a2). Bar = 50 mm.
FIG. 4. Bar graphs showing significant increases in the density of
vessels in the lesion boundary zone and the hippocampus.
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(MNSS, corner turn test, and Morris water maze test) in this
study have been used to evaluate the functional responses
and the effect of drugs on the functional recovery in rats
subjected to TBI.13 Our data demonstrate that damage to the
cortex induces significant asymmetric functional responses
in female rats, as reflected by the MNSS and results of the
corner turn test, and a deficiency in spatial memory, as mea-
sured by the Morris water maze test. Treatment with ator-
vastatin for 1 week significantly promotes recovery of the
spatial memory function on Day 15 after TBI. Note, how-
ever, that no significant difference was measured on the
MNSS and the corner turn test between the atorvastat-
in- and saline-treated groups at this time point. In contrast,
results of our previous study in male rats showed that
atorvastatin significantly improves sensorimotor and spatial
memory functions in male rats 15 days post-TBI.15 There-
fore, based on these data, one can infer that atorvastatin
treatment causes different functional responses to the same
treatment in male and female rats despite similar brain dam-
age. The reason for the sex effect on atorvastatin treatment
of TBI is unknown. The present study was not designed to
compare directly the effect of sex on responses to treatment
with atorvastatin. Nevertheless, we noted that the volume of
the cerebral infarct in male rats was 23.4%13 compared with
10.7% in the female rats reported on here. Thus, we may
speculate that the intrinsic neuroprotection in female rats,
which is characterized by a smaller lesion, may alter the re-
sponse pattern of the statin therapy. Note, however, that the
functional deficits, as measured using the MNSS (Score 12)
and the corner turn test (Score 1) 1 day after TBI, were sim-
ilar to values in the present study in the female rat (MNSS
13 and corner turn test Score 2). Thus, we cannot attribute
the differences in the response to statin treatment to differ-
ences in somatosensory deficits, although the lesion vol-
umes appear to be different. Additional studies are required
to compare directly within a single study the sex effects on
statin treatment of TBI.
Histological data revealed that atorvastatin treatment sig-
nificantly enhances the number of surviving neurons in the
lesion boundary zone and the hippocampal CA3 region but
does not reduce lesion volume on Day 15 after TBI. These
data are consistent with the findings from the study in male
rats with TBI, indicating that the effects of atorvastatin in
female rats with TBI can also be mediated by the modula-
tion of cellular constituents in the lesion boundary zone and
the hippocampal CA3 region post-TBI.15 Increased num-
bers of surviving neurons in the hippocampal CA3 region
have been reported to improve the spatial learning outcome
in rats and mice post-TBI10—results that can be attributed to
a more intact neural circuit after atorvastatin treatment com-
pared with that in the control rat. Nevertheless, no signifi-
cant improvement in sensorimotor function was measured
following atorvastatin treatment in female rats compared
with saline treatment. Although the number of surviving
neurons increased in the lesion boundary zone, the percent-
age of neurons with processes did not. This result perhaps
contributed to the lack of sensorimotor function differences
between atorvastatin- and saline-treated groups. 
Our current and previous data indicate that atorvastatin
treatment reduces neuron loss and the loss of neuronal pro-
cesses in the lesion boundary zone and the hippocampal
CA3 region post-TBI in both female and male rats.12 The
mechanisms underlying this protection perhaps are medi-
ated by a reduction in secondary injury post-TBI. Atorva-
statin reduces delayed thrombosis, maintains the integrity
of the microvasculature, and induces angiogenesis, all of
which enhance blood perfusion in the areas of interest.14,15
As demonstrated in this study, atorvastatin increases vascu-
lar density in the lesion boundary zone and the hippocam-
pal CA3 region. Atorvastatin also reduces damage caused
by the intracerebral hemorrhage to surrounding neurons.22
Endogenous neuroplasticity may also be enhanced by the
atorvastatin treatment via increasing neurogenesis and syn-
aptogenesis following brain injury.3,12
Conclusions
Atorvastatin improves spatial memory but not sensori-
motor function in female rats after TBI. This beneficial ef-
fect of atorvastatin perhaps is mediated by the reduction in
neuronal death and the loss of neuronal processes as well as
enhanced vascular density in the lesion boundary zone and
the hippocampal CA3 regions after TBI. 
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